Other Species / Isoforms
  MAGE-G1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S24
RDRDWSHSGNPGASR
0 1
MAGE-G1 (human) RDRDWSHSGNPGASR S24
MAGE-G1 (mouse) PERDWGGAGEEGPST A24
MAGE-G1 (rat) RERDWGGsGEEAPST S51-p
D41-ca
EDARVLRdGFAEEAP
0 1
MAGE-G1 (human) EDARVLRdGFAEEAP D41-ca
MAGE-G1 (mouse) gap -
MAGE-G1 (rat) gap -
S49-p
GFAEEAPsTsRGPGG
0 2
MAGE-G1 (human) GFAEEAPsTsRGPGG S49-p
MAGE-G1 (mouse) GAGEEGPSTSRAAGG S30
MAGE-G1 (rat) GsGEEAPSTSRGAGG S57
S51-p
AEEAPsTsRGPGGsQ
0 3
MAGE-G1 (human) AEEAPsTsRGPGGsQ S51-p
MAGE-G1 (mouse) GEEGPSTSRAAGGSS S32
MAGE-G1 (rat) GEEAPSTSRGAGGTS S59
S57-p
TsRGPGGsQGsQGPs
0 39
MAGE-G1 (human) TsRGPGGsQGsQGPs S57-p
MAGE-G1 (mouse) TSRAAGGSSQGSRAS S38
MAGE-G1 (rat) TSRGAGGTSQGSRAS T65
S60-p
GPGGsQGsQGPsPQG
0 34
MAGE-G1 (human) GPGGsQGsQGPsPQG S60-p
MAGE-G1 (mouse) gap -
MAGE-G1 (rat) gap -
S64-p
sQGsQGPsPQGARRA
Upstream
0 40
Regulatory protein:
  • OGT (human)
Treatment
  • EGF
  • nocodazole
MAGE-G1 (human) sQGsQGPsPQGARRA S64-p
MAGE-G1 (mouse) SRAAGGSSQGSRASL S39
MAGE-G1 (rat) SRGAGGTSQGSRASL S66
K83-ub
AVGPRSQkQLELKVS
0 2
MAGE-G1 (human) AVGPRSQkQLELKVS K83-ub
MAGE-G1 (mouse) TVGPRTQKQLELKVA K57
MAGE-G1 (rat) TVGPRTQKQLELKVA K84
K113-ub
IKRADILkHVIGDYK
0 1
MAGE-G1 (human) IKRADILkHVIGDYK K113-ub
MAGE-G1 (mouse) IKRTDILKHVVGDYR K87
MAGE-G1 (rat) IKRTDILKHVVGDYR K114
K128-ub
DIFPDLFkRAAERLQ
0 1
MAGE-G1 (human) DIFPDLFkRAAERLQ K128-ub
MAGE-G1 (mouse) DVYPNLLKLAAERLQ K102
MAGE-G1 (rat) DVYPNLLKLAAERLQ K129
K141-ub
LQYVFGYkLVELEPK
0 1
MAGE-G1 (human) LQYVFGYkLVELEPK K141-ub
MAGE-G1 (mouse) LQYVFGYKLVELEPK K115
MAGE-G1 (rat) LQYVFGYKLVELEPK K142
K221-ub
LIFGDPKkLITEDFV
0 1
MAGE-G1 (human) LIFGDPKkLITEDFV K221-ub
MAGE-G1 (mouse) LIFGDPKKLITEDFV K195
MAGE-G1 (rat) LIFGDPKKLITEDFV K222
Y246-p
PHTDPVDyEFQWGPR
0 11
MAGE-G1 (human) PHTDPVDyEFQWGPR Y246-p
MAGE-G1 (mouse) PHTDPVDYELQWGPR Y220
MAGE-G1 (rat) PHTDPVDYELQWGPR Y247
T254-p
EFQWGPRtNLETSkM
0 1
MAGE-G1 (human) EFQWGPRtNLETSkM T254-p
MAGE-G1 (mouse) ELQWGPRTNLETSKM T228
MAGE-G1 (rat) ELQWGPRTNLETSKM T255
K260-ac
RtNLETSkMKVLKFV
0 1
MAGE-G1 (human) RtNLETSkMKVLKFV K260-ac
MAGE-G1 (mouse) RTNLETSKMKVLKFV K234
MAGE-G1 (rat) RTNLETSKMKVLKFV K261
S298-p
NRARPQPsGPAPSs_
0 1
MAGE-G1 (human) NRARPQPsGPAPSs_ S298-p
MAGE-G1 (mouse) RARPATASAPATSS_ S273
MAGE-G1 (rat) SRARPAASGLATSS_ S299
S304-p
PsGPAPSs_______
Upstream
0 6
Treatment
  • hesperadin
  • MG132
  • nocodazole
MAGE-G1 (human) PsGPAPSs_______ S304-p
MAGE-G1 (mouse) ASAPATSS_______ S279
MAGE-G1 (rat) ASGLATSS_______ S305